Ryzneuta Injection
Product Images NDC 72893-016

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ryzneuta (NDC 72893-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Acrotech Biopharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Label (Carton Label 04dec2024)

Carton Label (Carton Label 04dec2024)
This is a description of a prescription medicine called Ryzneuta. It is a sterile solution containing the active ingredient efbemalenograstim alfa-vuxw, a recombinant dimeric human granulocyte colony-stimulating factor Fc fusion protein. The medicine is intended for subcutaneous injection by healthcare providers only. Each 1 mL prefilled syringe contains 20 mg of the active ingredient in a clear, colorless solution with specific ingredients. There are instructions on storage, caution about natural rubber latex in the packaging, and details about the manufacturer and distributor. It also provides NDC code, Dosage, and other important information for healthcare professionals.*
FDA Label Image

Syringe Label (Container Label 04dec2024)

Syringe Label (Container Label 04dec2024)
This text provides information about Ryzneuta®, a medication containing 20 mg/mL of efbemalenograstim alfa-vuxw for subcutaneous use. It comes in a single-dose prefilled syringe. The manufacturer is Evive Biotechnology Singapore Pte. Ltd., and it is distributed by Acrotech Biopharma Inc. located in East Windsor, NJ, USA. The National Drug Code (NDC) for this product is 72893-016-02.*
FDA Label Image

Tray Lid Label (Tray Lid Label 04dec2024)

Tray Lid Label (Tray Lid Label 04dec2024)
This text provides information about a medication called "EVIVEE" in the form of a prefilled syringe containing 20 mg of efbemalenograstim, a granulocyte colony-stimulating factor. It includes details on the ingredients, storage instructions, dosage, and manufacturer. The medication is recommended for subcutaneous use only and caution is advised due to the presence of natural rubber latex in the packaging which may cause allergic reactions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.